Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2008

Oct 29, 2008

32418_dirs_2008-10-29_585804c9-629e-4c99-9e16-dd8a71a11f01.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2008-10-20

Reporting Person: Jaksch Tricia A (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6225155 Indirect

Footnotes

F1: The reporting person and her husband, Frank L. Jaksch, Jr. are the sole co-general partners of Black Sheep, F.L.P., a family limited partnership. The reporting person, her husband and the 2008 Jaksch Family Trust UTD June 25, 2008, Frank L. Jaksch, Jr. and Tricia A. Jaksch Trustees are the sole limited partners of Black Sheep, F.L.P.